Efficacy and safety of trimethoprim/sulfamethoxazole combined with caspofungin for the treatment of acquired immunodeficiency syndrome patients with moderate to severe pneumocystis pneumonia

摘要

＜正＞Objective To assess the efficacy and safety of trimethoprim/sulfamethoxazole （TMP/SMZ） combined with caspofungin for the treatment of acquired immunodeficiency syndrome （AIDS） patients with moderate to severe pneumocystis pneumonia （PCP） requiring mechanical ventilation.Methods The clinical data of AIDS patients who admitted to Chongqing Public Health Medical Center from March 1,2019 to March 1,2021 with moderate to severe PCP requiring mechanical ventilation were retrospectively analyzed.